Cardiopulmonary Manifestations of Systemic Sclerosis

Chest - Tập 91 Số 1 - Trang 118-127 - 1987
Gregory R. Owens1, William P. Follansbee1
1From the Divisions of Pulmonary Medicine and Cardiology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh

Tóm tắt

Từ khóa


Tài liệu tham khảo

Medsger, 1985, Systemic sclerosis (scleroderma), eosinophilic fasciitis, and calcinosis

LeRoy, 1985, Scleroderma (systemic sclerosis)

Follansbee, 1986, The cardiovascular manifestations of systemic sclerosis (scleroderma), Current Prob Cardiol, 11, 242, 10.1016/0146-2806(86)90022-8

Steen, 1985, Pulmonary involvement in systemic sclerosis (scleroderma), Arth Rheum, 28, 759, 10.1002/art.1780280706

Owens G, Medsger T, Steen V. Unpublished data.

D’Angelo, 1969, Pathologic observations in systemic sclerosis (scleroderma), Am J Med, 46, 428, 10.1016/0002-9343(69)90044-8

Young, 1978, Pulmonary vascular changes in scleroderma, Am J Med, 64, 998, 10.1016/0002-9343(78)90455-2

Stupi, 1986, Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis, Arth Rheum, 29, 515, 10.1002/art.1780290409

Guttadauria, 1977, Pulmonary function in scleroderma, Arth Rheum, 20, 1071, 10.1002/art.1780200506

Owens, 1983, Pulmonary function in progressive systemic sclerosis: comparison of CREST syndrome variant with diffuse scleroderma, Chest, 84, 546, 10.1378/chest.84.5.546

Furst, 1981, Abnormalities of pulmonary vascular dynamics and inflammation in early progressive systemic sclerosis, Arth Rheum, 24, 1403, 10.1002/art.1780241111

Baron, 1983, 67Gallium lung scans in progressive systemic sclerosis, Arth Rheum, 26, 969, 10.1002/art.1780260805

Silver, 1984, Interstitial lung disease in scleroderma: Analysis of bronchoalveolar lavage, Arth Rheum, 27, 1254, 10.1002/art.1780271107

Konig, 1984, Lung involvement in scleroderma, Chest, 85, 318, 10.1378/chest.85.3.318

Edelson, 1985, Lung inflammation in scleroderma: clinical, radiographic, physiologic, and cytopathological features, J Rheum, 12, 957

Owens, 1986, The role of inflammation in the lung disease of systemic sclerosis: comparison with idiopathic pulmonary fibrosis, J Lab Clin Med, 107, 253

Martin, 1982, Alveolar macrophages from patients with idiopathic pulmonary fibrosis contribute to lung cell injury, Am Rev Respir Dis, 125, 91

Hunninghake, 1980, Human alveolar macrophage-derived chemotactic factor for neutrophils: Stimuli and partial characterization, J Clin Invest, 66, 473, 10.1172/JCI109878

Merrill, 1980, Alveolar macrophage derived chemotactic factors: Kinetics of in vitro production and partial characterization, J Clin Invest, 65, 268, 10.1172/JCI109668

Rossi, 1985, Evidence for chronic inflammation as a component of the interstitial lung disease associated with progressive systemic sclerosis, Am Rev Respir Dis, 131, 612, 10.1164/arrd.1985.131.4.612

Weiss, 1943, Scleroderma heart disease, with a consideration of certain other visceral manifestations of scleroderma, Arch Intern Med, 71, 749, 10.1001/archinte.1943.00210060010002

Medsger, 1971, Survival with systemic sclerosis (scleroderma). A life-table analysis of clinical and demographic factors in 309 patients, Ann Intern Med, 75, 369, 10.7326/0003-4819-75-3-369

Oram, 1961, The heart in scleroderma, Br Heart J, 23, 243, 10.1136/hrt.23.3.243

Sackner, 1964, The pathophysiology of scleroderma involving the heart and respiratory system, Ann Intern Med, 60, 611, 10.7326/0003-4819-60-4-611

Sackner, 1966, The heart in scleroderma, Am J Cardiol, 17, 542, 10.1016/0002-9149(66)90246-3

Bulkley, 1976, Myocardial lesions of progressive systemic sclerosis; a cause of cardiac dysfunction, Circulation, 53, 483, 10.1161/01.CIR.53.3.483

Follansbee, 1984, Physiologic abnormalities of cardiac function in progressive systemic sclerosis with diffuse scleroderma, N Engl J Med, 310, 142, 10.1056/NEJM198401193100302

Follansbee, 1986, Myocardial fibrosis in scleroderma: a case-controlled clinicopathologic study, Arth Rheum, 29, S52

McWhorter, 1974, Pericardial disease in scleroderma (systemic sclerosis), Am J Med, 57, 566, 10.1016/0002-9343(74)90008-4

Smith, 1979, Echocardiographic features of progressive systemic sclerosis (PSS); correlation with hemodynamic and postmortem studies, Am J Med, 66, 28, 10.1016/0002-9343(79)90478-9

Gottdiener, 1979, Echocardiographic identification of cardiac abnormality in scleroderma and related disorders, Am J Med, 66, 391, 10.1016/0002-9343(79)91057-X

Uhl, 1979, Pericardial tamponade in systemic sclerosis (scleroderma), Br Heart J, 42, 345, 10.1136/hrt.42.3.345

Meltzer, 1956, Pericardial effusion in generalized scleroderma, Am J Med, 20, 638, 10.1016/0002-9343(56)90145-0

Follansbee, 1984, Myocardial function and perfusion in the CREST syndrome variant of progressive systemic sclerosis; exercise radionuclide evaluation and comparison with diffuse scleroderma, Am J Med, 77, 489, 10.1016/0002-9343(84)90110-4

Windesheim, 1958, Electrocardiograms of ninety patients with acrosclerosis and progressive diffuse sclerosis (scleroderma), Circulation, 17, 874, 10.1161/01.CIR.17.5.874

Escudero, 1958, The electrocardiogram in scleroderma: analysis of 60 cases and review of the literature, Am Heart J, 56, 846, 10.1016/0002-8703(58)90193-5

Clements, 1981, The relationship of arrhythmias and conduction disturbances to other manifestations of cardiopulmonary disease in progressive systemic sclerosis (PSS), Am J Med, 71, 38, 10.1016/0002-9343(81)90256-4

Ridolfi, 1976, The cardiac conduction system in progressive systemic sclerosis; clinical and pathologic features of 35 patients, Am J Med, 61, 361, 10.1016/0002-9343(76)90373-9

Follansbee, 1985, The electrocardiogram in systemic sclerosis (scleroderma); study of 102 consecutive cases with functional correlations and a review of the literature, Am J Med, 79, 183, 10.1016/0002-9343(85)90008-7

Loperfido, 1982, Severe involvement of the conduction system in a patient with scleroderma heart disease. An electrophysiologic study, Acta Cardiol, 37, 31

James, 1974, DeSubitaneis Mortibus VIII. Coronary arteries and conduction system in scleroderma heart disease, Circulation, 50, 844, 10.1161/01.CIR.50.4.844

Lev, 1966, Systemic scleroderma with complete heart block; report of a case with comprehensive study of the conduction system, Am Heart J, 72, 13, 10.1016/0002-8703(66)90622-3

Roberts, 1981, The prevalence of conduction defects and cardiac arrhythmias in progressive systemic sclerosis, Ann Intern Med, 94, 38, 10.7326/0003-4819-94-1-38

Bulkley, 1978, Angina pectoris, myocardial inferction, and sudden cardiac death with normal coronary arteries; a clinicopathologic study of 9 patients with progressive systemic sclerosis, Am Heart J, 95, 563, 10.1016/0002-8703(78)90297-1

Norton, 1970, Vascular disease in progressive systemic sclerosis (scleroderma), Ann Intern Med, 73, 317, 10.7326/0003-4819-73-2-317

Campbell, 1975, Pathogenesis of systemic sclerosis: a vascular hypothesis, Arth Rheum, 4, 351, 10.1016/0049-0172(75)90017-7

Farmer, 1960, Prognostic significance of Raynaud’s phenomenon and other clinical characteristics of systemic scleroderma. A study of 271 cases, Circulation, 21, 1088, 10.1161/01.CIR.21.6.1088

Naslund, 1981, A documented episode of pulmonary vasoconstriction in systemic sclerosis, Johns Hopkins Med J, 148, 7

Wise, 1982, The effect of cold exposure on diffusing capacity in patients with Raynaud’s phenomenon, Chest, 81, 695, 10.1378/chest.81.6.695

Fahey, 1984, Raynaud’s phenomenon of the lung, Am J Med, 76, 263, 10.1016/0002-9343(84)90783-6

Shuck, 1985, Pulmonary vascular response during Raynaud’s phenomenon in progressive systemic sclerosis, Am J Med, 78, 221, 10.1016/0002-9343(85)90430-9

Alexander, 1981, Scleroderma heart disease: evidence for cold-induced abnormalities of myocardial function and perfusion, Arth Rheum, 24, S58

Siegel, 1984, Left ventricular function at rest and during Raynaud’s phenomenon in patients with scleroderma, Am Heart J, 108, 1469, 10.1016/0002-8703(84)90694-X

Kahan, 1986, Nifedipine and thallium-201 myocardial perfusion in progressive systemic sclerosis, N Engl J Med, 314, 1397, 10.1056/NEJM198605293142201

Kahan, 1985, Decreased coronary reserve in primary scleroderma myocardial disease, Arth Rheum, 28, 637, 10.1002/art.1780280607

Brown, 1925, Skin capillaries in scleroderma, Arch Intern Med, 36, 73, 10.1001/archinte.1925.00120130076008

Maricq, 1980, Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders, Arth Rheum, 23, 183, 10.1002/art.1780230208

Norton, 1968, Evidence of microvascular injury in scleroderma and systemic lupus erythematosus: quantitative study of the microvascular bed, J Lab Clin Med, 71, 919

Norton, 1970, Comparison of the microangiopathy of systemic lupus erythematosus, dermatomyositis, scleroderma, and diabetes mellitus, Lab Invest, 22, 301

Pisko, 1979, Cardiopulmonary manifestations of progressive systemic sclerosis: association circulating immune complexes and fluorescent antinuclear antibodies, Arth Rheum, 22, 518, 10.1002/art.1780220512

Bernstein, 1982, Association of antinuclear and antinucleolar antibodies in progressive systemic sclerosis, Clin Exp Immunol, 48, 43

Lapenas, 1978, Immunopathology of the renal vascular lesion of progressive systemic sclerosis (scleroderma), Am J Pathol, 91, 243

Haynes, 1982, The immunopathology of progressive systemic sclerosis (PSS), Arth Rheum, 11, 331, 10.1016/0049-0172(82)90055-5

Inoshita, 1981, Abnormalities of T-lymphocyte subsets in patients with progressive systemic sclerosis, J Lab Clin Med, 97, 264

Salem, 1976, Lymphocyte response to mitogen in progressive systemic sclerosis, Arth Rheum, 19, 875, 10.1002/art.1780190507

Postlethwaite, 1976, The chemotactic attraction of human fibroblasts to a lymphocyte-derived factor, J Exp Med, 144, 1188, 10.1084/jem.144.5.1188

Kondo, 1976, Cutaneous antigen-stimulating lymphokine production by lymphocytes of patients with progressive systemic sclerosis (scleroderma), J Clin Invest, 58, 1388, 10.1172/JCI108594

Stuart, 1976, Evidence for cell mediated immunity to collagen in progressive systemic sclerosis, J Lab Clin Med, 88, 601

Mackel, 1982, Antibodies to collagen in scleroderma, Arth Rheum, 25, 522, 10.1002/art.1780250505

Fleishmajer, 1976, Cellular infiltrates in scleroderma skin, Arth Rheum, 20, 975, 10.1002/art.1780200410

Wilson, 1964, An early pulmonary physiologic abnormality in progressive systemic sclerosis (diffuse scleroderma), Am J Med, 36, 361, 10.1016/0002-9343(64)90162-7

Kallenberg, 1984, The T. Steroid-responsive interstitial pulmonary disease in systemic sclerosis, Chest, 86, 489, 10.1378/chest.86.3.489

Ohar, 1985, The role of vasodilators in patients with progressive systemic sclerosis: interstitial lung disease and pulmonary hypertension, Chest, 88, 263S

Steen, 1985, The effect of D-penicillamine on pulmonary findings in systemic sclerosis, Arth Rheum, 28, 882, 10.1002/art.1780280807

Medsger, 1983, Progressive systemic sclerosis, Clin Rheum Dis, 9, 655, 10.1016/S0307-742X(21)00651-2

Bagg, 1979, Serial pulmonary function tests in progressive systemic sclerosis, Thorax, 34, 224, 10.1136/thx.34.2.224

Peters-Golden, 1984, Clinical and demographic predictors of loss of pulmonary function in systemic sclerosis, Med, 63, 221, 10.1097/00005792-198407000-00004

Steen V, Owens G, Medsger T. Unpublished data

Owens G. Unpublished data